B-cell lymphoma study identifies traits tied to greatest benefit from CD19 CAR T cell therapy

In the largest study of its kind, researchers from The University of Texas MD Anderson Cancer Center identified three subgroups of patients with large B-cell lymphoma (LBCL) who have different levels of benefit from CD19 chimeric antigen receptor (CAR) T cell therapy.
š Full Story

Baltimore Squatters STEAL Taxpayer Funded Housing
- The Best Space Battles Of The Expanse - Joshua Tyler
- Israel attacks Iran; Tehran vows revenge - Diana Zapata
- What is a brain age gap, and how may it affect thinking and memory skills?
- Announcing our 2025 VB Transform Innovation Showcase finalists - Aliyah Mohammed
- The iPhone 5S has officially become obsolete. What does this mean for Apple enthusiasts and tech lovers? - Michael A. Medeiros
- Scaly situation! Alligator spotted outside motel room in Fairfax County

This Lens Makes Life a Movie | GoPro Anamorphic
- Canal+ Buys African TV Group, As Telecom Deals Heat Up - John Njiraini
- 1980s Superhero Movies That Are Still Worth Watching - GFR
- 9 Delicious Ways To Eat More Dark Chocolate Without Overdoing It - Christina Manian, RDN
- Fmr Democrat Strategist Dan Turrentine Shares Real Reason Why People In His Party Are āVery Quietā About Iran - Mariane Angela
- TikTok's New Artist Account: A Revolution in Music Discovery - Bertha Stephens
- This chain restaurant has the highest employee satisfaction scores; here are the top 10